Abstract Library
Members may log into MY ENETS to visit the abstract library from previous ENETS conferences.
Participants of the ENETS Conference in 2024 can now access the abstract booklet, e-posters and videos, slide decks of talks, the poster carousel, and more via My ENETS.
ENETS Abstract Search
Introduction: Incidence of NETs is quoted to be 2/100,000 with approximately 25% being tumors of the midgut, (0.5/100,000). Incidence is increasing. However, this may be in part due to improved diagnosis but it is also thought to be a true increase.
Conference: 11th Annual ENETSConcerence (2014)
Presenting Author: Ardill J
Authors: Ardill J, Johnston B, Stronge W, Turner G, McCance D,
Keywords: MGC,
Introduction: Increased incidence of second malignancy is observed in NETs (Kamp et al 2012).
Conference: 10th Annual ENETSConcerence (2013)
Presenting Author: Ardill J
Authors: Ardill J, Johnston B, Stronge W, Turner G, McCance D,
Keywords: second malignancy, MGC,colon cancer,
Introduction: The biological mechanisms driving midgut carcinoid (MGC) are unknown. The purpose of this study is to explore the role of EGFR and c-Met signaling pathways in the pathogenesis.
Conference: 9th Annual ENETSConcerence (2012)
Presenting Author:
Authors: Liu E, Mikhitarian K, Revetta F, Shi C,
Keywords: carcinoid, EGFR, c-met, immunohistochemistry,
#508 Differential Expression of Markers in a Midgut Carcinoid Tissue Microarray
Introduction: Molecular mechanisms driving well-differentiated midgut carcinoid (MGC) tumors are not well-established. To pursue higher resolution tumor diagnostics, we studied a panel of markers for their expression in MGC, including: serotonin, FGF2, b-catenin, and E-cadherin, in primary, lymph node, and liver metastases.
Conference: 9th Annual ENETSConcerence (2012)
Presenting Author:
Authors: Liu E, Mikhitarian K, Revetta F, Shi C,
Keywords: midgut carcinoid, immunohistochemistry, markers,